Edesa Biotech is trading 7.41% up now at $4.16 after a broad market rebound.
- No company-specific announcement dated September 17, 2026, was identified; its official news page lists the latest releases as August 19, 2026 public-offering updates.
- The S&P 500, Nasdaq Composite, and Dow Jones rose 0.95%, 1.26%, and 0.56%, respectively, supporting a risk-on explanation.
- The move appears global rather than company-specific.